Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sunesis Pharmaceutic (SNSS)

Sunesis Pharmaceutic (SNSS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,452
  • Shares Outstanding, K 111,320
  • Annual Sales, $ 240 K
  • Annual Income, $ -26,620 K
  • 60-Month Beta 2.74
  • Price/Sales 273.88
  • Price/Cash Flow N/A
  • Price/Book 9.14
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/04/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.10
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.55 +4.59%
on 10/17/19
0.90 -36.67%
on 09/20/19
-0.26 (-30.98%)
since 09/18/19
3-Month
0.55 +4.59%
on 10/17/19
1.08 -47.36%
on 09/04/19
-0.34 (-37.31%)
since 07/18/19
52-Week
0.20 +185.00%
on 12/21/18
1.90 -70.00%
on 10/19/18
-1.27 (-69.02%)
since 10/18/18

Most Recent Stories

More News
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 26-30,...

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals Appoints Dr. Nicole Onetto to the Board of Directors

Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Dr. Nicole Onetto, M.D. has been appointed to the Sunesis Board of Directors. Dr. Onetto brings over 20 years of oncology drug development...

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals, Inc. (SNSS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Sunesis Pharmaceuticals, Inc. (SNSS).

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President of Finance and Corporate Development, will present at the Wells Fargo Healthcare...

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

Sunesis Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.

SNSS : 0.57 (-2.25%)
Sunesis: 2Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Sunesis Pharmaceuticals Inc. (SNSS) on Wednesday reported a loss of $6.2 million in its second quarter.

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals Reports Second Quarter 2019 Financial Results and Recent Highlights

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the quarter ended June 30, 2019. Loss from operations for the three and six months ended June 30, 2019 was $6.2 million...

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals to Host Conference Call on August 7th to Discuss Second Quarter 2019 Financial Results and Recent Highlights

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Wednesday, August 7, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results...

SNSS : 0.57 (-2.25%)
Sunesis Pharmaceuticals' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Sunesis Pharmaceuticals.

SNSS : 0.57 (-2.25%)
Sunesis Announces Pricing of $25 Million Offering of Securities

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced the pricing of underwritten public offerings of (i) 33,333,667 shares of its common stock and (ii) 8,333 shares of its non-voting Series F Convertible...

SNSS : 0.57 (-2.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade SNSS with:

Business Summary

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing...

See More

Key Turning Points

2nd Resistance Point 0.62
1st Resistance Point 0.59
Last Price 0.57
1st Support Level 0.56
2nd Support Level 0.54

See More

52-Week High 1.90
Fibonacci 61.8% 1.25
Fibonacci 50% 1.05
Fibonacci 38.2% 0.85
Last Price 0.57
52-Week Low 0.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar